Description
Synergistic Glycemic Control Galsit-Met, manufactured by Pharmatec, is specifically formulated to target different physiological pathways to regulate blood sugar levels.
Sitagliptin USP (as Sitagliptin Phosphate Monohydrate) works as a DPP-4 inhibitor, which enhances the body’s natural incretin hormones to increase insulin release after meals and decrease the amount of sugar made by the liver.
Metformin Hydrochloride B.P. works as a biguanide, helping to lower glucose production in the liver, increase insulin sensitivity, and reduce glucose absorption in the intestines.
Together, this dual-mechanism approach helps patients achieve smoother, more stable blood glucose management throughout the day.
Trusted Pharmaceutical Quality Each easy-to-swallow, film-coated tablet is precisely dosed with the 50 / 500 mg ratio to ensure therapeutic uniformity and reliability. The 14-tablet blister pack layout is perfect for early-stage therapy adoption, monthly titration monitoring, or short-term treatment planning under medical supervision. By combining two essential medications into a single pill, Galsit-Met helps simplify daily medication routines and supports long-term health compliance.
Reviews
There are no reviews yet.